{"id":55842,"date":"2023-04-14T15:06:49","date_gmt":"2023-04-14T13:06:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/oregonians-strongly-support-legislative-policies-to-require-pharmacy-benefit-managers-to-lower-drug-costs-provide-value\/"},"modified":"2023-04-14T15:06:49","modified_gmt":"2023-04-14T13:06:49","slug":"oregonians-strongly-support-legislative-policies-to-require-pharmacy-benefit-managers-to-lower-drug-costs-provide-value","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/oregonians-strongly-support-legislative-policies-to-require-pharmacy-benefit-managers-to-lower-drug-costs-provide-value\/","title":{"rendered":"Oregonians Strongly Support Legislative Policies to Require Pharmacy Benefit Managers to Lower Drug Costs & Provide Value"},"content":{"rendered":"
\n

\nNew Poll Finds 87% of Respondents Support Regulating PBMs<\/i><\/p>\n

SALEM, Ore.–(BUSINESS WIRE)–With the Beaver State already facing negative impacts of harmful business practices by pharmacy benefit managers (PBMs), a new poll among likely Oregon voters finds that an overwhelming majority support policy proposals to require these middlemen health insurance companies to lower drug costs and provide value to Oregonians.<\/p>\n

<\/a><\/p>\n

\nThe statewide poll found that 87% of likely Oregon voters across party lines support regulating PBMs<\/b>. <\/b>More than 3 out of 4 likely Oregon voters say regulating these middlemen health insurance companies should be a high or top priority for Congress and the state legislature<\/b>, and 82% of respondents state they are more or much more likely to vote for a candidate who supports PBM regulations<\/b>.<\/p>\n

\nThe findings of the state poll mirror those of a similar national poll<\/a> but with even higher levels of support among Oregonians for regulation and action; both polls were conducted by the bipartisan polling team of Lake Research Partners and Bellwether Research.<\/p>\n

\n\u201cIt\u2019s clear that Oregonians \u2013 like all Americans \u2013 are looking for actionable reforms to help make medicines more affordable and accessible. And that starts by building on the decades-long leadership of Chairman Wyden and others in Congress to enact legislation that holds PBMs accountable,\u201d said Mark Blum, Managing Director of the PBM Accountability Project.<\/p>\n

\nOregonians support a number of specific legislative policy provisions to regulate PBMs, including:<\/p>\n